Exon-skipping therapies Amondys 45 (casimersen) and Vyondys 53 (golodirsen) show “positive and encouraging trends” for people with Duchenne muscular dystrophy (DMD), even though top-line results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback